Search Results 2251-2260 of 17411 for gluten intolerance

  1. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    This phase II trial studies how well olaparib and cediranib maleate work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that ...

  2. Safety And Efficacy Of A Lysophosphatidic Acid Receptor Antagonist In Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  3. A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation - Mayo Clinic

    The purpose of this study is to determine whether oral rucaparib is effective in the treatment of patients with locally advanced or metastatic pancreatic cancer ...

  4. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    Gemcitabine hydrochloride may prevent tumor cells from multiplying by damaging their deoxyribonucleic acid (DNA) molecules that contain instructions for the ...

  5. Prospective Use of Real-time MRI - Mayo Clinic

    About this study. This research study is being done to look at a new MRI imaging software, Siemens Interventional Software, to see if we can improve our ...

  6. Collaborative Targeted Case Management in Improving Functional Status in Patients with Stage III-IV Cancer - Mayo Clinic

    About this study. This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV ...

  7. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

    This phase II study will test cancer to see if it has a HER2 mutation and, if so, see how HER2 mutated cancer responds to treatment with neratinib.

  9. Clinical Trials - Quality of Life Following Sacral Resection

    The purpose of this study is to survey patients who have undergone a sacrectomy (partial or total) at the Mayo Clinic. Participation eligibility. Participant ...

  10. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol - Mayo Clinic

    The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple ...